Yayın:
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, Serdal
dc.contributor.authorCaner Kapar
dc.contributor.authorBarış Köksal
dc.contributor.authorMustafa Seyyar
dc.contributor.authorPervin Can Şancı
dc.contributor.authorMurad Guliyev
dc.contributor.authorPerihan Perkin
dc.contributor.authorMustafa Büyükkör
dc.contributor.authorŞendağ Yaslıkaya
dc.contributor.authorNargız Majidova
dc.contributor.authorMerve Keskinkılıç
dc.contributor.authorDuygu Özaşkın
dc.contributor.authorTugay Avcı
dc.contributor.authorTuğçe Kübra Güneş
dc.contributor.authorMurat Arcagök
dc.contributor.authorAlper Topal
dc.contributor.authorGül Sema Yıldıran Keskin
dc.contributor.authorGözde Kavgacı
dc.contributor.authorNilgün Yıldırım
dc.contributor.authorOzde Melisa Celayir
dc.contributor.authorNilüfer Avcı
dc.contributor.authorFerit Aslan
dc.contributor.authorAli Alkan
dc.contributor.authorMert Erciyestepe
dc.contributor.authorMuhammet Cengiz
dc.contributor.authorMetin Pehlivan
dc.contributor.authorAhmet Gülmez
dc.contributor.authorİsmail Beypınar
dc.contributor.authorTuğba Başoğlu
dc.contributor.authorErkan Kayıkçıoğlu
dc.contributor.authorElvin Chalabiyev
dc.contributor.authorSerdal Turhal
dc.contributor.authorHalil Goksel Guzel
dc.contributor.authorE Ayas
dc.contributor.authorMustafa Şahbazlar
dc.contributor.authorÖzgecan Dülgar
dc.contributor.authorHacer Demir
dc.contributor.authorTuğba Yavuzşen
dc.contributor.authorİbrahim Vedat Bayoğlu
dc.contributor.authorDerya Kıvrak Salim
dc.contributor.authorBanu Öztürk
dc.contributor.authorFeyyaz Özdemir
dc.contributor.authorOğuz Kara
dc.contributor.authorBerna Öksüzoğlu
dc.contributor.authorÖznur Bal
dc.contributor.authorNebi Serkan Demirci
dc.contributor.authorMesut Yılmaz
dc.contributor.authorDevrim Çabuk
dc.contributor.authorSercan Aksoy
dc.contributor.orcid0000-0003-3060-377X
dc.contributor.orcid0000-0002-8879-8533
dc.contributor.orcid0000-0002-0418-5749
dc.contributor.orcid0000-0002-4841-7994
dc.contributor.orcid0000-0002-2981-8098
dc.contributor.orcid0000-0003-3994-815X
dc.contributor.orcid0000-0002-3458-525X
dc.contributor.orcid0000-0001-5264-8405
dc.contributor.orcid0000-0002-2575-5819
dc.contributor.orcid0000-0002-3342-3144
dc.contributor.orcid0009-0004-6376-8399
dc.contributor.orcid0000-0001-9652-7058
dc.contributor.orcid0000-0002-7917-2459
dc.contributor.orcid0000-0002-4058-6929
dc.contributor.orcid0000-0002-9679-9245
dc.contributor.orcid0000-0001-6858-6974
dc.contributor.orcid0000-0001-6960-2024
dc.contributor.orcid0000-0001-8198-2605
dc.contributor.orcid0000-0002-9153-6921
dc.contributor.orcid0000-0002-8253-5046
dc.contributor.orcid0000-0002-7590-6101
dc.contributor.orcid0000-0002-2028-9687
dc.contributor.orcid0000-0002-7214-9563
dc.contributor.orcid0000-0002-3353-344X
dc.contributor.orcid0000-0002-0853-4096
dc.contributor.orcid0000-0002-2059-5502
dc.contributor.orcid0000-0002-7401-5446
dc.contributor.orcid0000-0002-4107-9005
dc.contributor.orcid0000-0003-1857-593X
dc.contributor.orcid0000-0002-0678-4024
dc.contributor.orcid0000-0003-1235-9363
dc.contributor.orcid0000-0001-9375-8133
dc.contributor.orcid0000-0002-0481-1084
dc.contributor.orcid0000-0003-4107-3460
dc.contributor.orcid0000-0003-0702-6951
dc.contributor.orcid0000-0001-6980-2800
dc.contributor.orcid0000-0002-2756-8646
dc.contributor.orcid0000-0002-6901-2646
dc.contributor.orcid0000-0001-5943-889X
dc.contributor.orcid0000-0003-1466-3887
dc.contributor.orcid0000-0002-7871-6311
dc.contributor.orcid0000-0003-4984-1049
dc.date.accessioned2025-11-13T11:00:53Z
dc.date.issued2024-03-18
dc.identifier.doihttps://doi.org/10.1080/1120009x.2024.2330835
dc.identifier.endpage75
dc.identifier.issn1120-009X
dc.identifier.issue1
dc.identifier.openalexW4392926580
dc.identifier.startpage69
dc.identifier.urihttps://hdl.handle.net/11421/5953
dc.identifier.urihttps://doi.org/10.1080/1120009x.2024.2330835
dc.identifier.volume37
dc.language.isoen
dc.relation.ispartofJournal of Chemotherapy
dc.rightsrestrictedAccess
dc.subjectPalbociclib
dc.subjectMetastatic breast cancer
dc.subjectMedicine
dc.subjectNeutropenia
dc.subjectInternal medicine
dc.subjectFulvestrant
dc.subjectOncology
dc.subjectFebrile neutropenia
dc.subjectBreast cancer
dc.subjectCancer
dc.subjectAdverse effect
dc.subjectChemotherapy
dc.subjectEstrogen receptor
dc.subject.sdg3
dc.titleEfficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5019906736

Dosyalar

Koleksiyonlar

Publications